These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 631414)

  • 21. [The pharmacology of sulfinpyrazone (Anturan)].
    Rüegg M
    Wien Med Wochenschr Suppl; 1980; 61():3-8. PubMed ID: 6930768
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of retinal vein occlusions by a platelet antiaggregant: sulfinpyrazone (Anturan 200)].
    Constantinides G; Philibert P
    Bull Soc Ophtalmol Fr; 1986; 86(6-7):913-5. PubMed ID: 3829271
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases].
    Comberg HU; Janssen EJ; Diehm C; Zimmermann R; Harenberg J; Walter E; Oster P; Allenberg J; Horsch AK; Mörl H
    Vasa; 1983; 12(2):172-8. PubMed ID: 6349165
    [No Abstract]   [Full Text] [Related]  

  • 24. [Summary of the clinical papers on sulfinpyrazone (Anturan) under discussion with a preview of the current study program].
    Fontanilles F
    Wien Med Wochenschr Suppl; 1980; 61():23-4. PubMed ID: 6930767
    [No Abstract]   [Full Text] [Related]  

  • 25. Sulphinpyrazone metabolism during long-term therapy.
    Pedersen AK; Jakobsen P
    Br J Clin Pharmacol; 1981 Jun; 11(6):597-603. PubMed ID: 7272176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of sulfinpyrazone(Anturan) on the uric acid metabolism in malignant blood diseases].
    de Carvalho RI; Givisiez AN; Cardoso JR
    Hospital (Rio J); 1969 Apr; 75(4):1343-55. PubMed ID: 5306426
    [No Abstract]   [Full Text] [Related]  

  • 27. [The Anturan reinfarct study].
    Sherry S
    Wien Med Wochenschr Suppl; 1980; 61():17-22. PubMed ID: 6930766
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of sulfinpyrazone (anturan) on degree of vascular lesions and survival of cardiac allografts in rats.
    Vaessen LM; Bonthuis F; Hesse CJ; Lameijer LD
    Transplant Proc; 1977 Mar; 9(1):993-6. PubMed ID: 325835
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin requirements in diabetic patients treated with sulphinpyrazone.
    Pannebakker MA; den Ottolander GJ; ten Pas JG
    J Int Med Res; 1979; 7(4):328-31. PubMed ID: 488523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the blood coagulation system in thrombo-obliterative arteritis based on thromboelastographic studies].
    Knapik Z; Kurzawska-Mielecka M; Samplawska-Maj B; Wlodarczykowa J
    Pol Tyg Lek; 1970 Oct; 25(42):1577-9. PubMed ID: 5476519
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1969 Nov; 81(45):817-20. PubMed ID: 5362152
    [No Abstract]   [Full Text] [Related]  

  • 32. Thrombosis prevention by coagulation and platelet aggregtion inhibitors, in hyperlipemic rats.
    Renaud S; Lecompte F
    Thromb Diath Haemorrh; 1970 Dec; 24(3):577-86. PubMed ID: 5503948
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulphinpyrazone inhibits development of atherosclerosis in rabbits.
    Grodzińska L; Dembińska-Kieć A
    Artery; 1980; 8(5):426-30. PubMed ID: 7213049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex difference in antithrombotic effect of sulphinpyrazone.
    Pay GF; Wallis RB; Zelaschi D; Burley DM; Dalton M; Giorgiades E; Ginsburg J
    Lancet; 1982 Feb; 1(8269):461. PubMed ID: 6121137
    [No Abstract]   [Full Text] [Related]  

  • 35. Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets.
    Fabris F; Casonato A; Randi ML; Schivazappa L; Schiavinato L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(4):594-601. PubMed ID: 6196274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proceedings: The effect of sulphinpyrazone on the thrombocytopenia occurring in the Arthus reaction.
    Butler KD; White AM
    Br J Pharmacol; 1975 Oct; 55(2):256P-257P. PubMed ID: 127637
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on kinetics of anturan excretion in man.
    Seńczuk W; Jodynis-Liebert J
    Int J Clin Pharmacol Biopharm; 1979 Jul; 17(7):303-6. PubMed ID: 489196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of anturan in patients with ischemic heart disease with a history of acute myocardial infarction].
    Bokarev IN; Golikov AP; Liusov VA; Ptushkin VV; Zvereva TV
    Klin Med (Mosk); 1987 Oct; 65(10):29-32. PubMed ID: 3431051
    [No Abstract]   [Full Text] [Related]  

  • 39. [Thrombelastographic studies made to objectify the effects of Grisaldon upon the process of coagulation (author's transl)].
    Fröhlich M
    Zahn Mund Kieferheilkd Zentralbl; 1979; 67(6):579-82. PubMed ID: 160158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Symposium "The after care of myocardial infarct with the aggregation inhibitor ANTURAN 200 mg for the reduction of the mortality risk"].
    Wien Med Wochenschr Suppl; 1980; 61():1-31. PubMed ID: 6104875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.